+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum cathepsin activity in patients with malignant neoplastic diseases



Serum cathepsin activity in patients with malignant neoplastic diseases



Medecine Interne 24(2): 121-123



Serum cathepsin activity was estimated in 71 patients with various neoplastic diseases. Increased values were found in 76 per cent of the patients as compared to healthy blood donors.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029150095

Download citation: RISBibTeXText

PMID: 3726423


Related references

Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases A preliminary report. Medical Science Research 23(11): 741-742, 1995

Serum cathepsin b like activity in benign viral inflammatory pre neoplastic and neoplastic cervical lesions and pregnancy. Federation Proceedings: Abstract 1841, 1984

Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Research 12(1): 235-240, 1992

Studies of various tests for malignant neoplastic diseases. IV. The effect of zinc ion upon the serum, alkaline phosphatase activity. Journal of the National Cancer Institute 11(4): 739-755, 1951

Cathepsin B, L and D serum levels in patients with pancreatic cancer and non malignant pancreatic diseases. Proceedings of the American Association for Cancer Research Annual Meeting 36: 93, 1995

Elevated serum cathepsin B1-like activity in women with neoplastic disease. Gynecologic Oncology 7(1): 1-17, 1979

Tissue cathepsin b activity and serum inhibitory factor of cathepsin b activity in patients with liver cancer. Okayama Igakkai Zasshi 100(3-4): 351-360, 1988

On the activation of a cytostatic cyclo phosphamide anti neoplastic endoxan anti neoplastic by ionizing irradiations the possibility of the use of irradiated endoxan anti neoplastic in the therapy of neopl malignant diseases hela cell bovine serum. Sel'skokhozyaistvo za Rubezhom Rastenievodstvo 136(2): 241-249, 1968

The activity of alpha-amylase and its salivary isoenzymes in serum and urine of patients with neoplastic diseases of female reproductive organs. Roczniki Akademii Medycznej W Bialymstoku 41(2): 492-498, 1996

Serum seromucoid and acid mucopolysaccharide in malignant neoplastic diseases. Cancer 18(10): 1285-1291, 1965

Incidence of coexistent essential hypertension and malignant neoplastic diseases; study based on records of 509 clinic patients with and 509 without malignant neoplasms. American Journal of the Medical Sciences 232(5): 555-559, 1956

Fibrinolytic activity in malignant neoplastic diseases. Journal of the Association of Physicians of India 19(4): 293-296, 1971

Studies of various tests for malignant neoplastic diseases. VII. Serum inhibitors of chymotrypsin and trypsin. Journal of the National Cancer Institute 12(4): 861-876, 1952

Serum cathepsin B levels, urinary excretion of cathepsin B and tissue cathepsin B content in the patients with gastric cancer. Nihon Geka Hokan. Archiv für Japanische Chirurgie 62(5): 217-221, 1993

Studies of various tests for malignant neoplastic diseases. VIII. The determination of plasma or serum mucoprotein. American Journal of Clinical Pathology 24(7): 774-779, 1954